We participate in marketing programs, our editorial content is not influenced by any commissions. To find out more, please visit our Term and Conditions page.
We participate in marketing programs, our editorial content is not influenced by any commissions. To find out more, please visit our Term and Conditions page.
Windtree Therapeutics, a biopharmaceutical company that just implemented a BNB treasury strategy, witnessed its stock plummet more than 70% to $0.44 on Wednesday after...